Hori Shunta, Tanaka Nobumichi, Iida Kota, Nakai Yasushi, Miyake Makito, Anai Satoshi, Torimoto Kazumasa, Fujimoto Kiyohide
Department of Urology, Nara Medical University, Kashihara, Nara, 634-8522, Japan.
Res Rep Urol. 2021 Mar 24;13:155-165. doi: 10.2147/RRU.S299801. eCollection 2021.
Reports suggest that partial nephrectomy provides no significant benefit in terms of cancer-specific and overall survival (OS) compared to radical nephrectomy. Here, we focused on survival in terms of life expectancy and investigated the significance of partial nephrectomy for localized renal cell carcinoma (RCC) patients.
Our retrospective study included 937 patients (median age 63 years) with localized RCC who underwent partial nephrectomy or radical nephrectomy. Various predictive factors were explored, and the association between actual OS and life expectancy was analyzed.
Performance status (PS) ≥1 and tumor size ≥40 mm were identified as independent poor prognostic factors for cancer-specific survival. Age ≥60, male sex, PS ≥1, C-reactive protein elevation, pT1b stage, and radical nephrectomy were identified as independent poor prognostic factors for OS. OS and life expectancy did not differ in the partial nephrectomy group (P=0.11). OS was significantly shorter than life expectancy in the radical nephrectomy group (P<0.0001). In PS0 or pT1a patients, there was a significant difference between actual OS and life expectancy in the radical nephrectomy group (P<0.0001), but not in the partial nephrectomy group (P=0.15). In patients with a life expectancy ≥10 years, PS0, and pTa, OS and life expectancy differed in the radical nephrectomy group, but not in the partial nephrectomy group.
Partial nephrectomy can improve actual OS, and notably, PS and tumor size are crucial factors that determine the choice of surgical procedure. Further research is needed to establish appropriate treatment strategies and criteria for clinical practice.
报告表明,与根治性肾切除术相比,部分肾切除术在癌症特异性生存率和总生存率(OS)方面没有显著益处。在此,我们关注预期寿命方面的生存率,并研究部分肾切除术对局限性肾细胞癌(RCC)患者的意义。
我们的回顾性研究纳入了937例(中位年龄63岁)接受部分肾切除术或根治性肾切除术的局限性RCC患者。探索了各种预测因素,并分析了实际OS与预期寿命之间的关联。
体能状态(PS)≥1和肿瘤大小≥40 mm被确定为癌症特异性生存的独立不良预后因素。年龄≥60岁、男性、PS≥1、C反应蛋白升高、pT1b期和根治性肾切除术被确定为OS的独立不良预后因素。部分肾切除术组的OS和预期寿命无差异(P = 0.11)。根治性肾切除术组的OS显著短于预期寿命(P < 0.0001)。在PS0或pT1a患者中,根治性肾切除术组的实际OS与预期寿命之间存在显著差异(P < 0.0001),但部分肾切除术组无差异(P = 0.15)。在预期寿命≥10年、PS0和pTa的患者中,根治性肾切除术组的OS和预期寿命存在差异,但部分肾切除术组无差异。
部分肾切除术可改善实际OS,值得注意的是,PS和肿瘤大小是决定手术方式选择的关键因素。需要进一步研究以建立临床实践中合适的治疗策略和标准。